NASDAQ:CPIX

Cumberland Pharmaceuticals Stock Forecast, Price & News

$3.26

-0.04 (-1.21 %)

(As of 07/23/2021 12:00 AM ET)

Add

Compare

Today's Range

$3.26

▼

$3.33

50-Day Range

$2.78

▼

$3.45

52-Week Range

$2.58

▼

$3.94

Volume18,361 shs

Average Volume27,296 shs

Market Capitalization$49.06 million

P/E RatioN/A

Dividend YieldN/A

Beta0.23

30 days | 90 days | 365 days | Advanced Chart

Receive CPIX News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

COVID-19 health and safety protocols in Cumberland County School could be revised July 30
July 24, 2021 | msn.com

Cumberland global head Chris Zuehlke on crypto industry
July 22, 2021 | cnbc.com

Opioid-related deaths in Cumberland County nearly double over 5 year-period

Construction on new U.S. 60 Cumberland River Bridge ahead of schedule
July 21, 2021 | msn.com

Cumberland County District Attorney Billy West elected to lead national group
July 21, 2021 | msn.com

COVID-19 cases in Cumberland County rise more than 90% in a week
July 21, 2021 | msn.com

Ribbon cutting ceremony held for new Cumberland Trace Elementary
July 20, 2021 | msn.com

Tuesday will be a Code Orange Air Quality Action Day for Cumberland, Dauphin, Lancaster, Lebanon and York counties
July 19, 2021 | msn.com

Crash involving car, dump truck closes Route 1 in Cumberland
July 19, 2021 | msn.com

Cumberland County high school athletes to play in this week's East-West All-Star games in Greensboro
July 19, 2021 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:CPIX
Previous Symbol
CUSIP23077010
CIK1087294
Webwww.cumberlandpharma.com
Phone(615) 255-0068
Employees90
Year Founded1999

Sales & Book Value

Annual Sales$37.44 million
Price / Sales1.31
Cash Flow$0.25 per share
Price / Cash Flow13.12
Book Value$3.12 per share
Price / Book1.04

Profitability

EPS (Most Recent Fiscal Year)($0.06)
Net Income$-3,340,000.00
Net Margins-5.34%
Return on Equity3.75%
Return on Assets1.86%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares15,050,000
Market Cap$49.06 million
Next Earnings Date8/10/2021 (Estimated)
OptionableOptionable

Social Links

MarketRank^™

Overall MarketRank^™

0.77 out of 5 stars

Medical Sector

1301st out of 2,215 stocks

Pharmaceutical Preparations Industry

590th out of 867 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cumberland Pharmaceuticals.

2.2 Community Rank

Outperform Votes
Cumberland Pharmaceuticals has received 186 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cumberland Pharmaceuticals has received 244 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cumberland Pharmaceuticals has received 56.74% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cumberland Pharmaceuticals and other stocks. Vote “Outperform” if you believe CPIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CPIX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cumberland Pharmaceuticals does not currently pay a dividend.
Dividend Growth
Cumberland Pharmaceuticals does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cumberland Pharmaceuticals insiders have bought more of their company's stock than they have sold. Specifically, they have bought $38,237.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
41.19% of the stock of Cumberland Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 21.44% of the stock of Cumberland Pharmaceuticals is held by institutions.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Cumberland Pharmaceuticals is -23.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cumberland Pharmaceuticals is -23.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cumberland Pharmaceuticals has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Cumberland Pharmaceuticals (NASDAQ:CPIX) Frequently Asked Questions

Is Cumberland Pharmaceuticals a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cumberland Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cumberland Pharmaceuticals stock.
View analyst ratings for Cumberland Pharmaceuticals or view top-rated stocks.

What stocks does MarketBeat like better than Cumberland Pharmaceuticals?

Wall Street analysts have given Cumberland Pharmaceuticals a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cumberland Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cumberland Pharmaceuticals' next earnings date?

Cumberland Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Cumberland Pharmaceuticals.

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its earnings results on Monday, May, 10th. The specialty pharmaceutical company reported $0.07 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.14. The specialty pharmaceutical company earned $10.54 million during the quarter, compared to analysts' expectations of $8.50 million. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 3.75% and a negative net margin of 5.34%.
View Cumberland Pharmaceuticals' earnings history.

How has Cumberland Pharmaceuticals' stock been impacted by Coronavirus?

Cumberland Pharmaceuticals' stock was trading at $4.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CPIX stock has decreased by 21.3% and is now trading at $3.26.
View which stocks have been most impacted by COVID-19.

Who are Cumberland Pharmaceuticals' key executives?

Cumberland Pharmaceuticals' management team includes the following people:

A. J. Kazimi, Chairman & Chief Executive Officer
Leo B. Pavliv, Chief Development Officer & EVP-Operations
John Hamm, Chief Financial & Accounting Officer
Martin E. Cearnal, Director, Chief Compliance Officer & Executive VP
James L. Herman, Chief Compliance Officer & Senior Vice President

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals CEO A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among Cumberland Pharmaceuticals' employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cumberland Pharmaceuticals' key competitors?

Some companies that are related to Cumberland Pharmaceuticals include Johnson & Johnson (JNJ), Eli Lilly and (LLY), Pfizer (PFE), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT) and Supernus Pharmaceuticals (SUPN).
View all of CPIX's competitors.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), CorMedix (CRMD) and Xeris Pharmaceuticals (XERS).

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cumberland Pharmaceuticals' stock price today?

One share of CPIX stock can currently be purchased for approximately $3.26.

How much money does Cumberland Pharmaceuticals make?

Cumberland Pharmaceuticals has a market capitalization of $49.06 million and generates $37.44 million in revenue each year. The specialty pharmaceutical company earns $-3,340,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis.

How many employees does Cumberland Pharmaceuticals have?

Cumberland Pharmaceuticals employs 90 workers across the globe.

When was Cumberland Pharmaceuticals founded?

Cumberland Pharmaceuticals was founded in 1999.

What is Cumberland Pharmaceuticals' official website?

The official website for Cumberland Pharmaceuticals is www.cumberlandpharma.com.

Where are Cumberland Pharmaceuticals' headquarters?

Cumberland Pharmaceuticals is headquartered at 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203.

How can I contact Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The specialty pharmaceutical company can be reached via phone at (615) 255-0068 or via email at [email protected]

This page was last updated on 7/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here